SRNE

Sorrento Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.44 -5.71% 7.27 11:24:35
Close Price Low Price High Price Open Price Previous Close
7.05 7.66 7.65 7.71
more quote information »

Recent News

Date Time Source Heading
10/28/20206:42IHNWFeaturedELSE Nutrition Toddler Products to Launch in Over 380 U.S. Retail Locations in November 2020
10/28/20207:00IHNWFeatured256% INCREASE IN YEAR OVER YEAR SALES, REPORTS THUNDER ENERGIES CORP. (TNRG)
10/28/20204:05IHNWFeaturedOPTEC International, Inc. (OPTI) Launches OPTEC iWand Promotional Billboards Across Los Angeles, California
10/28/20207:45IHNWFeaturedCannabix Technologies Receives Notice of Allowance for Cannabis Drug Detection Device U.S. Patent
10/28/20206:55IHNWFeaturedSinglePoint Subsidiary Signs First of its Kind Agreement with Soligent, the Nation’s Largest Solar Materials Supplier
10/22/202017:26EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/22/202017:26EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/21/202016:17EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/21/202006:05EDGARNotice of Effectiveness (effect)
10/20/202017:22EDGARCurrent Report Filing (8-k)
10/20/202009:01EDGARStatement of Changes in Beneficial Ownership (4)
10/16/202016:31EDGARCurrent Report Filing (8-k)
10/14/202011:56GLOBEBrazilian Health Regulatory Agency (ANVISA) Authorizes..
10/13/202006:04EDGARCurrent Report Filing (8-k)
10/12/202017:20GLOBESorrento Adds Mesenchymal Stem Cell Program (MSC) That Has..
10/09/202019:46GLOBESorrento COVID-19 R&D October 13, 2020 Pipeline Call Details..
10/09/202013:09EDGARCurrent Report Filing (8-k)
10/08/202017:23EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/08/202016:16EDGARSecurities Registration Statement (simplified Form) (s-3)
10/07/202015:09GLOBESorrento Announces the Discovery of Salicyn-30 Small..
10/07/202006:00GLOBEScilex Holding Company, a Subsidiary of Sorrento..
10/04/202018:39GLOBESorrento to Host a R&D Day to Showcase COVID-19 Product..
10/02/202016:16EDGARCurrent Report Filing (8-k)
9/30/202017:22EDGARSecurities Registration Statement (simplified Form) (s-3)
9/30/202009:26GLOBESORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO..
9/30/202009:00GLOBESorrento Therapeutics and ViralClear Enter Into Agreement to..
9/29/202006:08EDGARCurrent Report Filing (8-k)
9/28/202023:59GLOBESorrento Releases Preclinical Data for STI-1499..
9/28/202016:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/28/202009:00GLOBESorrento Releases Positive Results of Phase 1B Trial of..
9/22/202014:30GLOBESorrento Therapeutics Releases Positive Results of Phase 1B..
9/17/202006:04EDGARCurrent Report Filing (8-k)
9/16/202021:30GLOBESorrento Receives US FDA Clearance to Proceed With Phase 1..
9/14/202006:04EDGARCurrent Report Filing (8-k)
9/14/202006:00GLOBESorrento Secures Exclusive License From Mayo Clinic for..
9/02/202009:10EDGARCurrent Report Filing (8-k)
9/02/202009:00GLOBESorrento Announces the Closing of Its Acquisition of..
8/21/202017:27EDGARProxy Statement - Notice of Shareholders Meeting..
8/21/202016:49EDGARInitial Statement of Beneficial Ownership (3)
8/20/202016:56EDGARCurrent Report Filing (8-k)
8/20/202016:05GLOBESorrento Enters Into Merger Agreement to Acquire SmartPharm..
8/19/202009:00GLOBESorrento Announces FDA IND Filing Today for COVI-GUARD..
8/18/202016:48EDGARCurrent Report Filing (8-k)
8/14/202019:45EDGARStatement of Changes in Beneficial Ownership (4)
8/12/202019:51GLOBESorrento to Take Action Against Hindenburg Research for..
8/10/202006:29EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/10/202006:28EDGARCurrent Report Filing (8-k)
8/04/202016:35EDGARQuarterly Report (10-q)
7/29/202009:02EDGARCurrent Report Filing (8-k)
7/29/202009:00PRNUSSorrento Announces License From Columbia University For..
7/24/202009:01EDGARCurrent Report Filing (8-k)
7/24/202009:00PRNUSSorrento Enters Into Letter Of Intent To Acquire SmartPharm..
7/20/202009:01EDGARCurrent Report Filing (8-k)
7/20/202009:00PRNUSFDA clears Abivertinib for Phase 2 safety and efficacy study..
7/17/202016:41EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.